Search for Clinical Trial Results

Sponsored By

Collecting Duct Carcinoma - 5 Studies Found

Status Study
Recruiting Study Name: Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (BEVABEL)
Condition: Collecting Duct Carcinoma (Kidney)
Date: 2015-02-09
Interventions: Drug: Bevacizumab Patients will be treated for a maximum o
Active, not recruiting Study Name: Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Condition: Renal Cell Carcinoma
Date: 2012-12-22
Interventions:
  • Drug: Sorafenib Sorafenib 400m
Recruiting Study Name: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
Condition:
  • Carcinoma of the Collecting Ducts of Bellini
  • Chromophobe Renal
    Date: 2013-01-10
    Interventions: Drug: Pazopanib Hydrochloride Given PO Other Names:
Active, not recruiting Study Name: Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Condition: Kidney Cancer
Date: 2010-08-18
Interventions:
  • Drug: Everolimus 10 mg by mout
Completed Study Name: Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer
Condition:
  • Renal Cell Cancer
  • Kidney Cancer

Date: 2007-04-20
Interventions: Drug: Sunitinib Malate 50 mg by mouth daily for 4 weeks, then 2 weeks off.